- Location
oral insulin
"-
ORMP Would Purchase an Aggregate of 1,580,000 Shares
Dec 30, 2013Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a developer of oral drug delivery systems, today announced that it has entered into definitive agreements with investors to purchase an aggregate of 1,580,000 shares of common stock at a price ...
Tags: Oramed Pharmaceuticals, Aegis Capital, registered direct offering
-
US FDA Has Cleared Oramed's Investigational New Drug Application for ORMD-0801
May 22, 2013The US Food and Drug Administration (FDA) has cleared Oramed's investigational new drug (IND) application for ORMD-0801, an oral insulin capsule, allowing the company to begin clinical trials of the drug. ORMD-0801 is an orally ingestible ...
Tags: FDA, Oral Insulin Capsule
-
Phase III Trial Results of Oral Insulin Generex Oral-Lyn to Indian Government for Approval
Jan 25, 2013Canada’s Generex Biotechnology, through its Indian licensee Shreya Life Sciences, has submitted a dossier of recently concluded Phase III trial results of its oral insulin ‘Generex Oral-lyn’ to the Indian government for ...
Tags: Generex Biotechnology, Shreya Life Sciences, oral insulin
-
Oramed Has Received Approximately $540,000 Government Grant in Israel
May 10, 2012Oramed, a wholly owned Israeli subsidiary of Oramed Pharmaceuticals, has received government grant of NIS2m (approximately $540,000) in Israel. The funds will be used to support R&D and clinical studies on the company's oral insulin ...
Tags: Oramed Pharmaceuticals, Medicine
